Skip to main
XYL
XYL logo

Xylem (XYL) Stock Forecast & Price Target

Xylem (XYL) Analyst Ratings

Based on 36 analyst ratings
Buy
Strong Buy 28%
Buy 36%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Xylem has demonstrated significant growth, with orders increasing by 8% on both a reported and organic basis, indicating robust demand for its water technology solutions. The company reported a notable 12% year-over-year growth in organic orders within its Measurement and Control Solutions (M&CS) segment, surpassing earlier estimates and consensus expectations. Additionally, Xylem's organic revenues grew 9% year-over-year, leading to an upward revision of its organic sales outlook for MCS, reflecting strong operational performance and market positioning.

Bears say

Xylem's fourth quarter of 2024 adjusted EPS guidance of $1.12-$1.14 fell short of expectations, reflecting soft revenues that were 3% below estimates and consensus, impacted by project timing at all segments. Additionally, the company experienced a modest decline of 1% in organic orders year-over-year, with a backlog of $5.2 billion also showing a slight decrease, leading to a book-to-bill ratio of approximately 1.0x. Despite reporting improved revenues, margins, and earnings per share while raising guidance, Xylem's stock nonetheless suffered a notable decline of 5.7%, indicating underlying concerns about operational performance and margin pressures projected for the second half of 2024.

Xylem (XYL) has been analyzed by 36 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 36% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Xylem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Xylem (XYL) Forecast

Analysts have given Xylem (XYL) a Buy based on their latest research and market trends.

According to 36 analysts, Xylem (XYL) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $101.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $101.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Xylem (XYL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.